ESHRE consensus on the definition of 'poor response to ovarian stimulation for in vitro fertilization: The Bologna criteria

Human Reproduction

Volumn 26, Issue 7, 2011, Pages 1616-1624

  Ferraretti, A P ^a   La Marca, A ^b   Fauser, B C J M ^c   Tarlatzis, B ^d   Nargund, G ^e   Gianaroli, L ^a  

^a SISMeR   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^e ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

2010 consensus; IVF; ovarian reserve; poor response

Indexed keywords

ARTICLE; BOLOGNA CRITERIA; CLINICAL ASSESSMENT; FERTILIZATION IN VITRO; HUMAN; MATERNAL AGE; METHODOLOGY; NOMENCLATURE; OOCYTE; OUTCOME ASSESSMENT; OVARIAN RESERVE; OVARY DISEASE; OVARY FUNCTION; POOR OVARIAN RESPONSE; RISK FACTOR;

EID: 79959426436     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der092     Document Type: Article

References (90)

1. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001;16:868-870. (Pubitemid 32451819)
2. Aletebi F. Comparing gonadotrophin-releasing hormone agonists or gonadotrophin-releasing hormone antagonists in poor responders in IVF. Fertil Soc J 2007;12:2-3.
3. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of POR in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002; 77:328-336. (Pubitemid 34083557)
4. Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546-553. (Pubitemid 351335051)
5. Beckers NG, Macklon NS, Eijkemans MJ, Fauser BC. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 2002;78:291-297. (Pubitemid 34831729)
6. Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil Steril 2008;90:1656-1661.
7. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718. (Pubitemid 44605509)
8. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of anti-Mullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91:705-714.
9. Broer SL, Mol B, Dólleman M, Fauser BC, Broekmans FJ. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010;22:193-201.
10. Brzyski R, Muasher S, Droesch K, Simonetti S, Jones G, Rosenwaks Z. Follicular atresia associated with concurrent initiation of gonadotrophin releasing hormone agonist and follicle stimulating hormone for oocytes recruitment. Fertil Steril 1988;50:917-921. (Pubitemid 19017963)
11. Cheung LP, Lam PM, Lok IH, Chiu TT, Yeung SY, Tjer CC, Haines CJ. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 2005;20:616-621. (Pubitemid 40425485)
12. Chong A, Rafael R, Forte C. Influence of weight in the induction of ovulation with human menopausal gonadotrophin and human chorionic gonadotropin. Fertil Steril 1986;46:599-603. (Pubitemid 17179952)
13. De Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, Van Leeuwen FE; OMEGA-project group. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-985. (Pubitemid 34497166)
14. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;11:911-921.
15. Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril 2009;92:481-485.
16. Detti L, Williams DB, Robins JC, Maxwell RA, Thomas MA. A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 2005;84:1401-1415.
17. Devroey P, Fauser BC, Diedrich K; Evian Annual Reproduction (EVAR) Workshop Group 2008. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2009;15:391-408.
18. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z. Value of suppression with a gonadotropin releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292-297. (Pubitemid 19050530)
19. Elter K, Sismanoglu A, Durmusoglu F. Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: a prospective study. Gynecol Endocrinol 2005;20:137-143. (Pubitemid 40694918)
20. El-Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve-an eight year study. Hum Reprod 2002;17:1519-1524. (Pubitemid 34661801)
21. Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, Muasher SJ. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998;69:826-830. (Pubitemid 28193914)
22. Fábregues F, Peñarrubia J, Creus M, Manau D, Casals G, Carmona F, Balasch J. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 2009;24:349-359.
23. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R. Exogenous follicle stimulating hormone ORT(EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod 1994;9:1607-1611. (Pubitemid 24291070)
24. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997; 18:71-106. (Pubitemid 27076456)
25. Fauser BC, Diedrich K, Devroey P; Evian Annual Reproduction Workshop Group 2007. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 2008;14:1-14.
26. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z. Minidose gonadotropin releasing hormone agonist is the treatment of choice in poor responders with high FSH levels. Fertil Steril 1994;62:343-346. (Pubitemid 24233286)
27. Ferraretti AP, Gianaroli L, Magli MC, Bafaro G, Colacurci N. Female poor responders. Mol Cell Endocrinol 2000;161:59-66. (Pubitemid 30201652)
28. Frattarelli JL, Hill MJ, McWilliams GD, Miller KA, Bergh PA, Scott RT Jr A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008a;89:1118-1122. (Pubitemid 351671736)
29. Frattarelli JL, McWilliams GD, Hill MJ, Miller KA, Scott RT Jr Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertil Steril 2008b;89:1113-1117. (Pubitemid 351671723)
30. Fridstrom M, Akerlof E, Sjoblom P, Hillensjo T. Serum levels of luteinizing and follicle-stimulating hormones in normal and poor responding patients undergoing ovarian stimulation with urofollitropin after pituitary down regulation. Gynecol Endocrinol 1997;11:25-28. (Pubitemid 27117007)
31. Garcia JE, Jones GS, Acosta AA, Wright G. HMG/hCGfollicular maturation for oocytes aspiration: phase II, 1981. Fertil Steril 1983; 39:174-179.
32. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009; 24:496-501.
33. Garcia-Velasco JA, Isaza V, Requena A, Mart́nez-Salazar FJ, Landazábal A, Remoh́ J, Pellicer A, Simón C. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod 2000;15:2292-2296.
34. Garcia-Velasco JA, Moreno L, Pacheco A, Guillén A, Duque L, Requena A, Pellicer A. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005;84:82-87. (Pubitemid 40991464)
35. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online 2009;19:385-390.
36. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with POR: a preliminary report. Hum Reprod 2004;19:2031-2035. (Pubitemid 39236469)
37. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996;17:121-155. (Pubitemid 26119956)
38. Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas 1998;30:137-142. (Pubitemid 28491354)
39. Goverde AJ, McDonnell J, Schats R, Vermeiden JP, Homburg R, Lambalk CB. Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only in older but also in younger women in couples with idiopathic and male subfertility. Hum Reprod 2005; 20:1573-1577. (Pubitemid 40852250)
40. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14:409-415. (Pubitemid 29097396)
41. Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A, Laufer N. Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril 1998;69:1001-1004. (Pubitemid 28274886)
42. IVF Wordwide Survey. Poor responders: how to define, diagnose and treat? Newsletter-August 8, 2010 (www.IVF-Worlwide.com).
43. Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle. Fertil Steril 2009;91:2437-2444.
44. Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining POR during IVF cycles, in women aged,40 years, and its relationship with treatment outcome. Hum Reprod 2004;19:1544-1547. (Pubitemid 38997178)
45. Karande V, Gleicher N. A rational approach to the management of low responders in IVF. Hum Reprod 1999;14:1744-1749.
46. Katayama K, Roesler M, Gunnarson G, Stehlik E, Jagusch S. Short term use of gonadotropin-releasing hormone agonist (leuprolide) for in vitro fertilization. J In Vitro Fert Embryo Transf 1988;5:332-337.
47. Keay SD, Barlow R, Eley A, Masson GM, Anthony FW, Jenkins JM. The relation between immunoglobulin G antibodies to Chlamydia trachomatis and poor ovarian response to gonadotropin stimulation before in vitro fertilization. Fertil Steril 1998;70:214-218. (Pubitemid 28361469)
48. Klinker ER, Frank JM, Broekmans FJ, Casper WN, Looman M, Te Velde ER. A poor response in the first cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril 2004;81:1247-1253. (Pubitemid 38609306)
49. Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC, Devroey P. Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Hum Reprod 2004;19:2550-2554. (Pubitemid 39481281)
50. Kwee J, Schats R, McDonnell J, Lambalk CB, Schoemaker J. Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod 2004;19:590-595. (Pubitemid 38344522)
51. Kyrou D, Kolibianakis E, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC . How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril 2009;91:749-766.
52. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
53. Land J, Yarmolinskaya M, Dumoulin J, Evers J. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996; 65:961-965. (Pubitemid 26126828)
54. Lass A, Skull J, McVeigh E, Margara R, Winston RM. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 1997;12:294-297. (Pubitemid 27129390)
55. Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 2003;18:527-533. (Pubitemid 36329319)
56. Loutradis D, Vomvolaki E, Drakakis P. Poor responder protocols for in-vitro fertilization: 0ptions and results. Curr Opin Obstet Gynecol 2008; 20:374-378.
57. Macklon NS, Stouffer RL, Giuduce LC, Fauser BC. The science behind 25years of ovarian stimulation for in vitro fertilization. Endocr Rev2006; 27:170-207.
58. Manzi D, Thorton K, Scott L, Nulsen J. The value of increasing the dose of HMG in women who initially demonstrate a poor response. Fertil Steril 1994;62:251-256. (Pubitemid 24233271)
59. Marci R, Caserta D, Farina M, Dessole S, Germond M, Tatone C. A prospective randomized comparison of two short stimulation protocol with agonist and antagonist of GnRH in poor responders patients undergoing IVF. Preliminary report. Hum Reprod 2003; 18:113.
60. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study. Hum Reprod 2006;21:1204-1211.
61. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21:200-214. (Pubitemid 32275595)
62. Molloy D, Martin M, Speirs A, Lopata A, Clarke G, McBain J, Ngu A, Johnston IH. Performance of patients with a 'frozen pelvis' in an in vitro fertilization program. Fertil Steril 1987;47:450-455. (Pubitemid 17054217)
63. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, Aragona C. A controller trial of natural cycle versus GnRH analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 2004;81:1542-1547. (Pubitemid 38748996)
64. Nargund G, Cheng WC, Parsons J. The impact of ovarian cystectomy on ovarian response to stimulation during in-vitro fertilization cycles. Hum Reprod 1996;11:81-83. (Pubitemid 26047675)
65. Nargund G, Fauser BC, Macklon NS, Ombelet W, Nykren K, Frydman R. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod 2007;22:2801-2804. (Pubitemid 351696817)
66. Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet 1987;1:645-647. (Pubitemid 17122877)
67. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 2007;15:2222-2229. (Pubitemid 350100744)
68. Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Intervention for poor responders to controlled ovarian hyper stimulation in IVF. Cochrane Database Syst Rev 2010;I:CD004379.
69. Pantos C, Thornton SJ, Speirs AL, Johnston I. Increasing the human menopausal gonadotropin dose-does the response really improve? Fertil Steril 1990;53:436-439. (Pubitemid 20093604)
70. Raga F, Bonilla-Musoles F, Casan EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod 1999;14: 1431-1434. (Pubitemid 29265428)
71. Rombauts L, Suikkari A, MacLachlan V, Trounson A, Healy D. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril 1998; 69:665-669. (Pubitemid 28188461)
72. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999; 72:845-851. (Pubitemid 29505448)
73. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro low ovarian response to stimulation for IVF fertilization patients with a microdose follicle-stimulating hormone are, growth hormone protocol. Fertil Steril 1997;67:93-97. (Pubitemid 26428419)
74. Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Fertil Steril 2008;89:151-156.
75. Scott RT Jr, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302. (Pubitemid 20256240)
76. Shaker A, Yates R, Flemming R, Coutts J, Jamieson M. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotrophins in women: normal and poor responders. Fertil Steril 1992;58:919-923.
77. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667-676. (Pubitemid 30154101)
78. Surrey ES, Bower JA, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist are regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419-424.
79. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76. (Pubitemid 36305584)
80. Tazegul A, Gorkemli H, Ozdemir S, Aktan TM. Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing IVF. Arch Gynecol Obstet 2008;278:467-472.
81. Tehraninejad ES, fazel A, Samiei A, Rashidi B, Kiani K. Flexible, multiple GnRH antagonist versus long GnRH agonist protocol in poor responders: a randomized controlled trial. Int J Fertil Steril 2009;2:165-168.
82. The Rotterdam ESHRE/ASRM sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risksrelatedtopolycystic ovary syndrome.Fertil Steril 2004;81:19-25.
83. Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997;12:220-223. (Pubitemid 27129375)
84. Toth T, Awwad J, Veeck L, Jones H, Mausher S. Suppression and are regimens of gonadotropin-releasing hormone agonist: use in women with different basal gonadotropin values in an in vitro fertilization program. J. Reprod Med 1996;41:321-326. (Pubitemid 26172565)
85. Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003;6:439-443. (Pubitemid 36849804)
86. Van Disseldorp J, Lambalk CB, Kwee J, Looman CW, Eijkemans MJ, Fauser BC, Broekmans FJ. Comparison of inter-and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 2010;25:221-227.
87. Verhagen TE, Hendriks DJ, Bancsi LF, Mol BW, Broekmans FJ. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Update 2008;14:95-100. (Pubitemid 351321105)
88. Weissman A, Farhi J, Royburt M, Nahum H, Glezerman M, Levran D. Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. Fertil Steril 2003;79:886-892. (Pubitemid 36385008)
89. Weitzman VN, Engmann L, Di Luigi A, Maier D, Nulsen J, Benadiva C. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Fertil Steril 2009;92:226-230.
90. Yarali H, Esinler I, Polat M, Bozdag G, Tiras B. Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol. Fertil Steril 2009;92:231-235.